These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3332433)

  • 21. Antiaggregant therapy and/or anticoagulant therapy in the cerebrovascular patient.
    Carolei A; Sacco S; Marini C
    Haematologica; 2001 Nov; 86(11 Suppl 2):36-9. PubMed ID: 11926774
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy.
    Kirshner HS
    Tenn Med; 1996 Nov; 89(11):410-2. PubMed ID: 8942279
    [No Abstract]   [Full Text] [Related]  

  • 23. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
    Robert S; Miller AJ; Fagan SC
    Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiaggregation therapy is a secondary prevention of ischemic stroke].
    Kamchatov PR; Chugunov AV; Umarova KhIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():58-64. PubMed ID: 19425370
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic effect of antiaggregants in patients with neurocirculatory asthenia with the initial signs of cerebral ischemia].
    Lebedev AA; Burdakov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):48-52. PubMed ID: 2158726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events.
    Lahiri P; Chaudhuri U; Chattopadhyay A; Chakraborty P; Mandal D; Dasgupta AK
    Blood Cells Mol Dis; 2005; 34(3):248-56. PubMed ID: 15885609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The platelet functions in stroke.
    Krajícková D; Malý J; Pecka M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):285-98. PubMed ID: 8599071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and therapeutic features of cerebral ischemic conditions].
    Lechner H; Schmidt R
    Ric Clin Lab; 1988; 18 Suppl 2():59-64. PubMed ID: 3247563
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombolytic therapy as early management of ischemic stroke.
    Killeen I
    Am Fam Physician; 1998 Jan; 57(1):24-6, 28-30. PubMed ID: 9447212
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serotonin content in the thrombocytes and the effect of acetylsalicylic acid on its rate of liberation in ischemic stroke].
    Bogoiavlenskaia NM
    Klin Med (Mosk); 1979 Sep; 57(9):51-4. PubMed ID: 491513
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
    Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of anticoagulants or antiplatelet aggregating drugs in the prevention of ischemic stroke.
    Adams HP
    Adv Intern Med; 1995; 40():503-31. PubMed ID: 7747656
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
    Gao BT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):148-51, 191. PubMed ID: 2591268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke therapy: status of anti-platelet aggregation drugs.
    Yatsu FM
    Neurology; 1977 Jun; 27(6):503-4. PubMed ID: 325429
    [No Abstract]   [Full Text] [Related]  

  • 38. American Heart Association issues management guidelines for acute ischemic stroke.
    Am Fam Physician; 1995 Apr; 51(5):1301-4. PubMed ID: 7709897
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic therapy for ischemic cerebrovascular disease.
    Dutka AJ; Hallenbeck JM
    Neurol Clin; 1990 Feb; 8(1):161-76. PubMed ID: 2181265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy in stroke and transient ischemic attacks.
    Feinberg W
    Am Fam Physician; 1989 Nov; 40(5 Suppl):53S-59S. PubMed ID: 2683695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.